TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TBRG

TruBridge Inc.

Healthcare · Health Information Services

26.20$ +0.0% vs. previous close Closing price · As of: Jul 13, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios TBRG
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
Valuation
71.2 – – – – – – – – 52.4 73.5 48.3
1.0 0.7 0.5 0.4 0.4 0.5 0.8 1.1 1.0 0.8 0.9 0.6
1.5 1.0 0.9 0.7 0.8 1.0 1.7 2.3 2.0 1.6 1.8 1.2
1.5 1.1 1.0 0.9 0.9 1.0 1.3 1.6 1.4 1.3 1.3 1.0
12.8 11.7 14.0 14.6 13.1 12.0 11.6 12.5 10.5 8.5 10.9 10.5
496.1 – – – – – 21.6 18.4 16.5 9.9 10.1 5.1
0.2% -0.7% -10.4% -20.5% -8.7% -6.1% 4.6% 5.4% 6.1% 10.1% 9.9% 19.7%
Margins
47.3% 47.1% 48.2% 46.6% 47.0% 47.6% 49.1% 52.1% 52.8% 53.2% 53.0% 51.2%
4.0% 1.0% -12.6% -13.8% -13.9% -11.7% 3.3% 4.9% 6.6% 7.2% 6.0% 6.0%
1.5% -0.2% -13.5% -15.3% -15.7% -17.5% -5.7% -4.8% -2.8% 1.6% 1.3% 1.3%
0.2% -0.5% -4.9% -8.0% -3.7% -3.1% 3.8% 6.2% 5.9% 8.4% 9.1% 12.1%
Returns
2.1% -0.4% -24.5% -27.8% -29.2% -34.2% -11.7% -10.0% -5.7% 3.1% 2.4% 2.5%
1.1% -0.2% -10.5% -12.3% -12.8% -14.7% -5.0% -4.3% -2.5% 1.4% 1.1% 1.1%
Balance Sheet & Debt
139 142 196 182 174 169 160 159 155 165 141 130
3.6 4.5 7.8 8.5 7.2 6.0 4.2 3.6 3.3 3.1 3.3 4.0
53.0% 53.1% 43.0% 44.3% 43.9% 43.0% 42.8% 43.3% 44.4% 45.2% 44.2% 43.8%
0.6 0.6 1.1 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9
Per Share
0.35 -0.06 -3.22 -3.61 -3.69 -4.13 -1.38 -1.17 -0.68 0.39 0.30 0.30
23.73 23.71 23.90 23.64 23.57 23.64 24.02 24.18 23.94 24.17 23.94 23.75
16.24 16.05 13.14 12.97 12.65 12.05 11.80 11.73 11.92 12.46 12.28 12.27
0.05 -0.11 -1.16 -1.88 -0.87 -0.73 0.91 1.50 1.42 2.03 2.19 2.88

Data as of: July 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?